Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 15035 | 27.6 |
09:34 ET | 1653 | 27.61 |
09:36 ET | 3566 | 27.56 |
09:38 ET | 1387 | 27.66 |
09:39 ET | 2049 | 27.68 |
09:41 ET | 3962 | 27.765 |
09:43 ET | 3358 | 27.78 |
09:45 ET | 3435 | 27.785 |
09:48 ET | 4142 | 27.79 |
09:50 ET | 2980 | 27.8 |
09:52 ET | 10105 | 27.815 |
09:54 ET | 2480 | 27.775 |
09:56 ET | 3040 | 27.803 |
09:57 ET | 2997 | 27.78 |
09:59 ET | 5131 | 27.8 |
10:01 ET | 1800 | 27.915 |
10:03 ET | 2382 | 27.83 |
10:06 ET | 6625 | 27.8 |
10:08 ET | 2604 | 27.77 |
10:10 ET | 13909 | 27.75 |
10:12 ET | 3186 | 27.74 |
10:14 ET | 2500 | 27.78 |
10:15 ET | 4995 | 27.765 |
10:17 ET | 7869 | 27.795 |
10:19 ET | 3686 | 27.76 |
10:21 ET | 4116 | 27.755 |
10:24 ET | 1338 | 27.755 |
10:26 ET | 5703 | 27.7557 |
10:28 ET | 4927 | 27.75 |
10:30 ET | 3035 | 27.745 |
10:32 ET | 800 | 27.75 |
10:33 ET | 5153 | 27.8 |
10:35 ET | 6711 | 27.82 |
10:37 ET | 2721 | 27.795 |
10:39 ET | 7821 | 27.805 |
10:42 ET | 1350 | 27.805 |
10:44 ET | 4442 | 27.79 |
10:46 ET | 4209 | 27.8 |
10:48 ET | 7238 | 27.825 |
10:50 ET | 3307 | 27.855 |
10:51 ET | 4369 | 27.84 |
10:53 ET | 6201 | 27.875 |
10:55 ET | 4381 | 27.855 |
10:57 ET | 8009 | 27.805 |
11:00 ET | 7116 | 27.79 |
11:02 ET | 2627 | 27.785 |
11:04 ET | 7859 | 27.8 |
11:06 ET | 7209 | 27.775 |
11:08 ET | 6662 | 27.775 |
11:09 ET | 1200 | 27.775 |
11:11 ET | 6538 | 27.765 |
11:13 ET | 4035 | 27.775 |
11:15 ET | 2389 | 27.765 |
11:18 ET | 3000 | 27.775 |
11:20 ET | 3271 | 27.79 |
11:22 ET | 700 | 27.785 |
11:24 ET | 6426 | 27.795 |
11:26 ET | 2637 | 27.805 |
11:27 ET | 4971 | 27.81 |
11:29 ET | 1344 | 27.805 |
11:31 ET | 12559 | 27.84 |
11:33 ET | 3361 | 27.815 |
11:36 ET | 4859 | 27.855 |
11:38 ET | 7588 | 27.815 |
11:40 ET | 2577 | 27.84 |
11:42 ET | 2417 | 27.86 |
11:44 ET | 3656 | 27.85 |
11:45 ET | 1049 | 27.85 |
11:47 ET | 5379 | 27.88 |
11:49 ET | 6060 | 27.875 |
11:51 ET | 4616 | 27.85 |
11:54 ET | 5054 | 27.875 |
11:56 ET | 2000 | 27.875 |
11:58 ET | 930 | 27.87 |
12:00 ET | 1400 | 27.885 |
12:02 ET | 6873 | 27.885 |
12:03 ET | 3650 | 27.875 |
12:05 ET | 2469 | 27.875 |
12:07 ET | 4114 | 27.875 |
12:09 ET | 1099 | 27.885 |
12:12 ET | 11822 | 27.885 |
12:14 ET | 2582 | 27.88 |
12:16 ET | 4169 | 27.88 |
12:18 ET | 4270 | 27.875 |
12:20 ET | 13024 | 27.885 |
12:21 ET | 4061 | 27.8999 |
12:23 ET | 417 | 27.9 |
12:25 ET | 5758 | 27.915 |
12:27 ET | 5821 | 27.92 |
12:30 ET | 1877 | 27.91 |
12:32 ET | 4041 | 27.915 |
12:34 ET | 3221 | 27.925 |
12:36 ET | 1933 | 27.93 |
12:38 ET | 600 | 27.94 |
12:39 ET | 100 | 27.94 |
12:41 ET | 1692 | 27.945 |
12:43 ET | 1106 | 27.945 |
12:45 ET | 300 | 27.9497 |
12:48 ET | 7420 | 27.965 |
12:50 ET | 100 | 27.965 |
12:52 ET | 527 | 27.97 |
12:54 ET | 4138 | 27.97 |
12:56 ET | 1680 | 27.985 |
12:57 ET | 8575 | 27.975 |
12:59 ET | 3960 | 27.995 |
01:01 ET | 1066 | 27.995 |
01:03 ET | 3918 | 28.015 |
01:06 ET | 6137 | 28.015 |
01:08 ET | 600 | 28.01 |
01:10 ET | 1074 | 28.015 |
01:12 ET | 2364 | 28.004 |
01:14 ET | 7740 | 27.985 |
01:15 ET | 100 | 27.985 |
01:17 ET | 2130 | 27.985 |
01:19 ET | 1520 | 27.995 |
01:21 ET | 7507 | 27.994 |
01:24 ET | 2612 | 27.98 |
01:26 ET | 1268 | 27.984 |
01:28 ET | 4924 | 27.985 |
01:30 ET | 7779 | 28.015 |
01:32 ET | 1026 | 28.01 |
01:33 ET | 1678 | 28.015 |
01:35 ET | 5297 | 28.025 |
01:37 ET | 4493 | 28.02 |
01:39 ET | 2949 | 28.025 |
01:42 ET | 1885 | 28.025 |
01:44 ET | 1903 | 28.025 |
01:46 ET | 3743 | 28.055 |
01:48 ET | 7094 | 28.045 |
01:50 ET | 3748 | 28.045 |
01:51 ET | 600 | 28.05 |
01:53 ET | 4467 | 28.035 |
01:55 ET | 2088 | 28.02 |
01:57 ET | 740 | 28.015 |
02:00 ET | 3976 | 28.035 |
02:02 ET | 8204 | 28.04 |
02:04 ET | 3877 | 28.03 |
02:06 ET | 1280 | 28.035 |
02:08 ET | 1890 | 28.035 |
02:09 ET | 4486 | 28.025 |
02:11 ET | 3711 | 28.005 |
02:13 ET | 4323 | 28.005 |
02:15 ET | 1355 | 28.015 |
02:18 ET | 2003 | 28.025 |
02:20 ET | 2164 | 28.035 |
02:22 ET | 700 | 28.035 |
02:24 ET | 6846 | 28.03 |
02:26 ET | 1129 | 28.035 |
02:27 ET | 675 | 28.035 |
02:29 ET | 2658 | 28.045 |
02:31 ET | 7172 | 28.04 |
02:33 ET | 4066 | 28.035 |
02:36 ET | 2346 | 28.03 |
02:38 ET | 207 | 28.0248 |
02:40 ET | 2229 | 28.05 |
02:42 ET | 7190 | 28.044 |
02:44 ET | 812 | 28.05 |
02:45 ET | 200 | 28.045 |
02:47 ET | 2258 | 28.055 |
02:49 ET | 3472 | 28.06 |
02:51 ET | 4647 | 28.08 |
02:54 ET | 1964 | 28.085 |
02:56 ET | 8898 | 28.085 |
02:58 ET | 2112 | 28.085 |
03:00 ET | 1805 | 28.09 |
03:02 ET | 7414 | 28.085 |
03:03 ET | 800 | 28.085 |
03:05 ET | 6082 | 28.085 |
03:07 ET | 584 | 28.09 |
03:09 ET | 1917 | 28.09 |
03:12 ET | 12447 | 28.09 |
03:14 ET | 6282 | 28.045 |
03:16 ET | 318 | 28.045 |
03:18 ET | 1834 | 28.05 |
03:20 ET | 5044 | 28.06 |
03:21 ET | 9201 | 28.035 |
03:23 ET | 600 | 28.035 |
03:25 ET | 510 | 28.035 |
03:27 ET | 10002 | 28.015 |
03:30 ET | 538 | 28.015 |
03:32 ET | 1877 | 28.015 |
03:34 ET | 6997 | 27.995 |
03:36 ET | 2489 | 28 |
03:38 ET | 5889 | 28.005 |
03:39 ET | 12367 | 28.015 |
03:41 ET | 3134 | 28.015 |
03:43 ET | 5212 | 28.03 |
03:45 ET | 4700 | 28.05 |
03:48 ET | 9484 | 28.07 |
03:50 ET | 11501 | 28.09 |
03:52 ET | 20324 | 28.135 |
03:54 ET | 17844 | 28.165 |
03:56 ET | 33784 | 28.165 |
03:57 ET | 52520 | 28.175 |
03:59 ET | 664038 | 28.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.7B | 18.7x | +1.83% |
Amneal Pharmaceuticals Inc | 2.6B | -13.4x | --- |
Endo Inc | 1.9B | 0.4x | --- |
Catalent Inc | 10.9B | -10.5x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 18.9x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.7B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.7x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 19.9x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.